MedPath
NMPA Approval

Levosimendan Injection

国药准字H20110104

May 10, 2021

国药准字H20110104

Drug Information

左西孟旦注射液

海合天欣

海合天欣

注射剂

5ml:12.5mg

化学药品

May 10, 2021

Company Information

Applicant Company

四川省成都市大邑县工业大道一段

Manufacturing Company

四川省成都市大邑县工业大道一段

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左西孟旦注射液 - NMPA 批准文号 | MedPath